Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice

Fig. 2

The effects of dapagliflozin on endothelium dependent- and -independent dilation. a Endothelium-dependent dilation; b area under of the curve for endothelium-dependent dilation (EDD); c endothelium-independent dilation; d area under of the curve for endothelium-independent dilation (EID). Data are expressed as mean ± SEM; *p < 0.05 vs, all other groups; #p < 0.05 vs both Db groups; $p < 0.05 vs Db group; n = 10–12/group

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840